Business Context and Reporting Period
Company: Medley Capital Corporation (Note: Input metadata listed "Phenixfin Corp," but the filing text identifies the registrant as Medley Capital Corporation).
Reporting Period: Quarter ended December 31, 2019.
Business Overview: Medley Capital Corporation is an externally managed, non-diversified closed-end management investment company regulated as a Business Development Company (BDC) under the Investment Company Act of 1940. The Company invests primarily in senior secured first and second lien term loans to privately held middle-market companies. It is currently in the process of merging with Sierra Income Corporation ("Sierra"), subject to stockholder and regulatory approvals.
Key Financial Metrics
| Metric | Q4 2019 | Q4 2018 |
|---|---|---|
| Net Investment Income | $3.07 million | $1.76 million |
| Net Increase in Net Assets from Operations | $4.17 million | $(10.08) million |
| Earnings Per Share (Basic & Diluted) | $0.08 | $(0.18) |
| Net Asset Value (NAV) Per Share | $4.05 | $5.61 |
| Total Investments (Fair Value) | $342.0 million | $396.9 million |
| Cash and Cash Equivalents | $81.7 million | $62.7 million |
| Total Debt Outstanding (Carrying Value) | $204.5 million | $251.7 million |
| Asset Coverage Ratio | 206.1% | 212.4% |
Material Changes vs. Prior Period
- Portfolio Reduction: Total investments at fair value decreased by approximately $54.9 million (13.8%) from $396.9 million to $342.0 million, driven by exits and repayments of $65.0 million against new investments of $6.7 million.
- Debt Reduction: Total debt carrying value decreased by $47.3 million. This was primarily due to the repayment of $135.0 million in SBA Debentures (completed in Q2 2019) and a $34.1 million prepayment of Israeli Notes in Q4 2019.
- Expense Volatility: Total expenses decreased significantly to $4.4 million from $12.4 million in the prior year. This reduction was largely due to a $4.4 million net credit in professional fees resulting from insurance reimbursements related to merger litigation and vendor discounts, offsetting standard operating costs.
- Realized Losses: The Company recognized a net realized loss of $1.7 million on investments, compared to $56.7 million in the prior year. The prior year's loss was driven by write-offs of two portfolio companies.
- Unrealized Gains: Net unrealized appreciation on investments was $3.7 million, a reversal from the $45.0 million unrealized depreciation recorded in the prior year.
Guidance, Outlook, Risks, and Contingencies
- Merger Status: The Company is pursuing a merger with Sierra Income Corporation. The exchange ratio is currently set at 0.66 shares of Sierra stock for each Medley share, based on a Delaware Court of Chancery ruling regarding plaintiff attorney fees. The Company and Sierra have filed an appeal regarding the fee award.
- Israeli Notes Covenant Risk: The Company is subject to a minimum net asset covenant of $215 million under its Israeli Notes. As of December 31, 2019, net assets were $220.6 million, providing a cushion of $5.6 million. Management states it is "reasonably likely" that net assets could decline below this threshold by March 31, 2020, potentially triggering a default if not remedied by waivers, amendments, or capital raises.
- Dividend Policy: No dividends were declared for the quarter ended December 31, 2019. The Company intends to distribute substantially all taxable income to maintain Regulated Investment Company (RIC) status but may retain earnings to meet covenant requirements.
- Legal Proceedings: A settlement was approved regarding a stockholder class action (Delaware Action) related to the merger. The settlement includes a fund of $17 million cash and $30 million of Sierra stock for the class, plus attorney fees. The Company recorded a receivable for $3.5 million in insurance proceeds related to these legal fees.
Investor Verification Checklist
- Covenant Compliance: Verify the Company's ability to maintain the $215 million net asset minimum required by the Israeli Notes in the upcoming quarter (Q1 2020).
- Merger Closing Conditions: Monitor the status of the appeal regarding the Delaware Court's attorney fee ruling and the subsequent impact on the merger exchange ratio and closing timeline.
- Portfolio Quality: Review the 4.7% of the portfolio (approx. $16.1 million) currently on non-accrual status and the specific performance of controlled investments like NVTN LLC and URT Acquisition Holdings Corporation.
- Debt Maturities: Assess the liquidity position relative to the $45.1 million in Israeli Notes principal payments due within one year.
- Expense Normalization: Evaluate future operating expenses excluding the one-time $4.4 million professional fee credit to understand the true recurring cost structure.